{
    "Trade/Device Name(s)": [
        "Platelia Aspergillus EIA",
        "PlateliaTM Aspergillus EIA",
        "Platelia\u2122M Aspergillus EIA"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K060641",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023857"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NOM"
    ],
    "Summary Letter Date": "June 2, 2006",
    "Summary Letter Received Date": "March 10, 2006",
    "Submission Date": "February 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3040"
    ],
    "Regulation Name(s)": [
        "Aspergillus Spp. Serological Reagents"
    ],
    "Analyte Class(es)": [
        "mycology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Aspergillus galactomannan antigen"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Microplate",
        "Spectrophotometer (450 and 620/630 nm)"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoenzymatic sandwich assay",
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Microplate EIA",
        "Immunoenzymatic sandwich"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Platelia Aspergillus EIA immunoenzymatic assay for detection of Aspergillus galactomannan antigen in serum",
    "Indications for Use Summary": "Aid in the diagnosis of invasive aspergillosis in adults and pediatric patients by detecting Aspergillus galactomannan antigen in serum samples, for use in conjunction with other diagnostic procedures.",
    "fda_folder": "Microbiology"
}